Biofrontera Inc.
Biofrontera Inc. (BFRI) Stock Overview
Explore Biofrontera Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
10M
P/E Ratio
-0.52
EPS (TTM)
$-1.50
ROE
29.95%
BFRI Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Biofrontera Inc. (BFRI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 51.33, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $14.24.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.52 and a market capitalization of 10M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.